
|Articles|September 1, 2006
Novel occlusive patch improves responses to topical psoriasis medications
Interim results from an open-label controlled clinical study indicate that occlusion with a specially designed hydrogel patch safely and significantly enhances the efficacy of a variety of topical medications that are used in the treatment of psoriasis, reported researchers from the University of California at the American Academy of Dermatology's Summer Academy '06.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
2
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025
3
Expert Panel Unanimously Backs DecisionDx-Melanoma for Guiding Personalized Cancer Care
4
Considering Biologics and Shared Decision-Making in Moderate to Severe Plaque Psoriasis: Part 2
5

















